Optaflu

Edit

Research and Markets: PharmaPoint: Seasonal Influenza Vaccines - France Drug Forecast and Market Analysis

18 Jan 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/z8k68j/pharmapoint) has announced the addition of GlobalData's new report "PharmaPoint. Seasonal Influenza Vaccines France Drug Forecast and Market Analysis" to their offering. “PharmaPoint. Seasonal Influenza Vaccines France Drug Forecast and Market Analysis” ... Sanofi is the market leader in France ... - Fluarix/FluLaval ... - Optaflu ... Source ... ....(size: 5.9Kb)

Edit

Research and Markets: PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis

Business Wire

18 Jan 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/44jgql/pharmapoint) has announced the addition of GlobalData's new report "PharmaPoint. Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis" to their offering. “PharmaPoint. Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis” ... Scope ... Reasons to buy ... Product Profiles - Major Brands ... - FluMist ... - Optaflu ... ....(size: 5.6Kb)

Edit

Research and Markets: PharmaPoint: Seasonal Influenza Vaccines United Kingdom - Drug Forecast and Market Analysis

Business Wire

18 Jan 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/8964xt/pharmapoint) has announced the addition of GlobalData's new report "PharmaPoint. Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis" to their offering. “PharmaPoint. Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis” ... The market leader is GSK's Fluarix ... Scope ... - Optaflu ... Source ... ....(size: 5.7Kb)

Edit

Research and Markets: Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

Business Wire

14 Jan 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/44w3gw/optaflu_seasonal) has announced the addition of GlobalData's new report "Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis" to their offering. “Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis” ... The cell culture-based manufacturing process differentiates Optaflu from its competitors....(size: 5.2Kb)

Edit

Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose

PR Newswire

31 Oct 2012

  Google. , Oct. 31, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.. Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose ... Summary ... Key trends in terms of M&A and licensing agreements are also analyzed ... Scope ... Reasons to buy ... 6.3.2 Optaflu 81 ... US ... ....(size: 27.1Kb)

Edit

Germany recalls some Novartis flu shots

Jamaica Observer

26 Oct 2012

BERLIN — German authorities ordered a recall of some batches of Novartis flu vaccine yesterday as a precautionary measure after the company reported the appearance of small particles in the manufacturing process ... Klaus Cichutek said in a statement. The decision affects four batches of the influenza vaccine Begripal and one batch of Fluad. It does not affect the seasonal vaccine Optaflu ... Influpozzi Adiuvato and Influpozzi Subunita ... ....(size: 2.0Kb)

Edit

Germany orders recall of some Novartis flu shots

Fox News

26 Oct 2012

German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process ... Klaus Cichutek said in a statement. The decision affects four batches of the influenza vaccine Begripal and one batch of Fluad. It does not affect the seasonal vaccine Optaflu ... Influpozzi Adiuvato and Influpozzi Subunita ... ....(size: 2.7Kb)

Edit

Novartis Flu Vaccine: Germany Orders Recall After Small Particles Found In Shots

Huffington Post

26 Oct 2012

BERLIN — German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process ... Klaus Cichutek said in a statement. The decision affects four batches of the influenza vaccine Begripal and one batch of Fluad. It does not affect the seasonal vaccine Optaflu ... Influpozzi Adiuvato and Influpozzi Subunita ... ....(size: 4.8Kb)

Edit

Global Human Vaccines Industry

PR Newswire

26 Jul 2012

RESEARCH BREAKTHROUGHS - A HISTORIC PERSPECTIVE BUILDER II-82Favrille Announces Phase III Registration Trial Results ofSpecifid in Patients with Follicular B-Cell Non-Hodgkin'sLymphoma II-82Novartis Announces Phase III Results of Menveo® Vaccine II-82Emergent Commences Phase II Clinical Study of Typhoid Vaccine II-82AVANT's Single-Dose Oral ......(size: 60.8Kb)

Edit

Vaccine Manufacturing Technology and Services: World Market 2011-2021

PR Newswire

28 Nov 2011

 . , Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.. Vaccine Manufacturing Technology and Services. World Market 2011-2021. http.//www.reportlinker.com/p0692158/Vaccine-Manufacturing-Technology-and-Services-World-Market-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication. Report Details ... 1 ... 2 ... 2.6.4.1 Optaflu (Novartis) ... 3 ... 4....(size: 51.5Kb)

Edit

Reportlinker Adds World Influenza Vaccines Market 2011-2021

PR Newswire

05 Apr 2011

 . , April 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.. World Influenza Vaccines Market 2011-2021. http.//www.reportlinker.com/p0470100/World-Influenza-Vaccines-Market-2011-2021.html ... There, you will see commercial opportunities for influenza vaccines - original research, data and opinions ... CCR Ref number ... 8.2.1 Acquisition of Chiron - Optaflu Cell-Based Vaccine ... ....(size: 80.4Kb)

Make changes yourself !

History [link]

References [link]

http://wn.com/Optaflu

Make changes yourself !

History[link]

References[link]

http://wn.com/Optaflu

History [link]

References [link]